Literature DB >> 23229451

First face-off in RA biologic therapy declared a draw.

Emma Leah.   

Abstract

Year:  2012        PMID： 23229451     DOI： 10.1038/nrrheum.2012.222

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  3 in total

Review 1.  Safety of biologic therapy in rheumatoid arthritis.

Authors:  Robert S Woodrick; Eric M Ruderman
Journal:  Nat Rev Rheumatol       Date:  2011-10-11       Impact factor: 20.543

Review 2.  Unresolved issues in biologic therapy for rheumatoid arthritis.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

3.  Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.

Authors:  Michael E Weinblatt; Michael Schiff; Robert Valente; Désirée van der Heijde; Gustavo Citera; Cathy Zhao; Michael Maldonado; Roy Fleischmann
Journal:  Arthritis Rheum       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.